Fecal microbiota transplantation for patients with active ulcerative colitis: A cost-effectiveness analysis.

Yao, Jiaqi; Fekadu, Ginenus; Ng, Siew C; You, Joyce H S

Yao, Jiaqi; Fekadu, Ginenus; Ng, Siew C; You, Joyce H S.

Afiliação

Yao J; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
Fekadu G; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
Ng SC; Microbiota I-Center, The Chinese University of Hong Kong, Hong Kong.
You JHS; Department of Medicine and Therapeutics, LKS Institute of Health Science, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

J Gastroenterol Hepatol ; 38(1): 70-78, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36181412

Assuntos

Colite Ulcerativa; Transplante de Microbiota Fecal; Humanos; Colite Ulcerativa/terapia; Análise de Custo-Efetividade; Análise Custo-Benefício; Enema; Resultado do Tratamento

Palavras-chave

cost-effectiveness analysis; fecal microbiota transplantation; quality-adjusted life-years; remission; ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Transplante de Microbiota Fecal Tipo de estudo: Etiology_studies / Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: J Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Hong Kong

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google